Ontology highlight
ABSTRACT:
SUBMITTER: Rybinski K
PROVIDER: S-EPMC4694842 | biostudies-other | 2015 Sep
REPOSITORIES: biostudies-other
Rybinski Katherine K Imtiyaz Hongxia Z HZ Mittica Barrie B Drozdowski Brian B Fulmer James J Furuuchi Keiji K Fernando Shawn S Henry Marianne M Chao Qimin Q Kline Brad B Albone Earl E Wustner Jason J Lin JianMin J Nicolaides Nicholas C NC Grasso Luigi L Zhou Yuhong Y
Oncotarget 20150901 28
Over-expression of endosialin/CD248 (herein referred to as CD248) has been associated with increased tumor microvasculature in various tissue origins which makes it an attractive anti-angiogenic target. In an effort to target CD248, we have generated a human CD248 knock-in mouse line and MORAb-004, the humanized version of the mouse anti-human CD248 antibody Fb5. Here, we report that MORAb-004 treatment significantly impacted syngeneic tumor growth and tumor metastasis in the human CD248 knock-i ...[more]